Date: July 19, 2026
Regulatory Action on Subsidiary
Optival Health Solutions Private Limited, a subsidiary of MedPlus Health Services Limited, has received a suspension order for a Drug License of one store located in Karnataka.
Suspension Details
- Authority: Assistant Director, Drugs Control Administration, Vijayapura Circle
- Nature of Action: Suspension of Drug License for two days
- Store Location: Indi Sindagi Road Bijapur, Karnataka
- Date of Order Receipt: July 18, 2026
- Regulatory Basis: Violation under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules
- Financial Impact: Potential revenue loss of ₹0.53 lakhs (quantified in monetary terms)
Disclosure Context
Additional Information
The announcement will be available on the company's website (www.medplusindia.com) and on the websites of BSE Limited (www.bseindia.com) and National Stock Exchange of India Ltd. (www.nseindia.com).
Sections Not Specified
- KMP / Board / Auditor Changes
- Dividend Declaration or Non-Declaration
- Board Meeting Outcomes
- Financial Results
- Auditor's Report
- Disinvestment / Strategic Actions
- Media Release / Investor Communication
- Other Operational / Legal / Strategic Disclosures